Overcoming acquired osimertinib-resistance in EGFR-mutant advanced non-small lung cancer mediated by activating BRAF V600E mutation. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting ...
A previous study demonstrated that power against the (unobserved) true effect for the primary end point (PEP) of most phase III oncology trials is low, suggesting an increased risk of false-negative ...
Understanding the mechanics of adaptive evolution requires not only knowing the quantitative genetic bases of the traits of interest but also obtaining accurate measures of the strengths and modes of ...
The highest mortality rate was associated with vascular diseases: as many as 6758 deaths (11.95%) were reported in patients with these conditions. The next 3 groups of diseases with the highest ...
The main purpose of this paper is to clarify relations and distinctions between several approaches suggested in the statistical literature for analysing structures in correlation matrices, i.e. of ...